Zevra Therapeutics, Inc. · NASDAQ:ZVRA
McFarlane Neil F. sold 20,000 Zevra Therapeutics, Inc. shares (Form 4)
Traded Oct 10 to Oct 12, 2026 · Filed Oct 13, 2026
From Oct 10 to Oct 12, 2026, McFarlane Neil F. (Director, President and CEO) sold 20,000 Zevra Therapeutics, Inc. shares at US$11.25 for US$225K under a trading plan, leaving 417,225 shares. Filed Oct 13, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$11.25
- Value
- US$225K
- Holding after
- 417,225 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 10, 2026 | Common Stock | Option exercise | 50,000 | 437,225 | Direct | |
| Oct 12, 2026 | Common Stock | Sale | 20,000 | US$11.25 | 417,225 | Direct |
Source
Related
- Zevra Therapeutics, Inc.
- McFarlane Neil F.
- Zevra Therapeutics, Inc. shareholders
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026